Palatin Technologies Inc. (PTN)

[sorkin]

Why rallying?

It will fail miserably! This is why:-

In clinical trials, the FDA said about 25% of patients treated with Vyleesi benefited from an increase in sexual desire score, compared with about 17% who took a placebo. About 40% of patients in clinical trials experienced nausea, most commonly in those who used the drug, and 13% needed medications to treat the side effect, the FDA said in a statement.

“There was no difference between treatment groups in the change from the start of the study to end of the study in the number of satisfying sexual events,” according to the FDA statement.